Effect of cocaine sensitization of α1-adrenoceptors in brain regions of the rat: An autoradiographic analysis

Pharmacological Reports

Volumn 58, Issue 6, 2006, Pages 827-835

  Nalepa, Irena ^a   Witarski, Tadeusz ^a   Kowalska, Marta ^a   Filip, Małgorzata ^a   Vetulani, Jerzy ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Autoradiography; Brain structure; Cocaine sensitization; Rat; 3H prazosin binding; 1 adrenergic receptor

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR; COCAINE; PRAZOSIN;

AMYGDALOID NUCLEUS; ARTICLE; AUTORADIOGRAPHY; BRAIN; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; RECEPTOR DENSITY; SENSITIZATION; THALAMUS NUCLEUS; WITHDRAWAL SYNDROME;

EID: 33846295554     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Anderson SM, Pierce RC: Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther, 2005, 106, 389-403.
2. Arnsten AF: Catecholamine regulation of the prefrontal cortex. J Psychopharmacol, 1997, 11, 151-162.
3. Arnsten AF, Mathew R, Ubriani R, Taylor JR, Li BM: Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry, 1999, 45, 26-31.
4. Auclair A, Cotecchia S, Glowinski J, Tassin JP: D-Amphetamine fails to increase extracellular dopamine levels in mice lacking α 1b-adrenergic receptors: Relationship between functional and nonfunctional dopamine release. J Neurosci, 2002, 22, 9150-9154.
5. Blanc G, Trovero F, Vezina P, Herve D, Godeheu AM, Glowinski J, Tassin JP: Blockade of prefronto-cortical α1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci, 1994, 6, 293-298.
6. Bremner DJ, Krystal JH, Southwick SM, Charney DS: Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse, 1996, 2328-2338.
7. Carlezon Jr, WA, Wise RA: Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci, 1996, 16, 3112-3122.
8. Cecchi M, Khoshbouei H, Morilak DA: Modulatory effects of norepinephrine, acting on alpha-1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology, 2002, 43, 1139-1147.
9. Chefer VI, Shippenberg TS: Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience, 2002, 112, 907-919.
10. Corbit LH, Muir JL, Balleine BW: The role of the nucleus accumbens in instrumental conditioning: evidence of a functional dissociation between accumbens core and shell. J Neurosci, 2001, 21, 3251-3260.
11. Covington HE 3rd, Miczek KA: Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress. Eur J Pharmacol, 2003, 467, 1-13.
12. Darracq L, Blanc G, Glowinski J, Tassin JP: Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci, 1998, 18, 2729-2739.
13. Di Ciano P, Everitt RJ: Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J Neurosci, 2004, 24, 7167-7173.
14. Drouin C, Blanc G, Villegier AS, Glowinski J, Tassin JP: Critical role of α1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: Influence of pre-exposure conditions and pharmacological characteristics. Synapse, 2002, 43, 51-61.
15. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP: α1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci, 2002, 22, 2873-2884.
16. Dudish-Poulsen S, Hatsukami DK: Acute abstinence effects following smoked cocaine administration in humans. Exp Clin Psychopharmacol, 2000, 8, 472-482.
17. Filip M, Papla I, Nowak E, Przegaliński E: Blocking impact of clozapine on cocaine locomotor and sensitizing effects in rats. Pol J Pharmacol, 2003, 55, 1125-1130.
18. Fuchs RA, Evans KA, Parker MC, See RE: Differential involvement of the core and shell subregions of the nucleus accumbens in conditioned cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl), 2004, 176, 459-465.
19. Fung YK, Richard LA: Behavioural consequences of cocaine withdrawal in rats. J Pharm Pharmacol, 1994, 46, 150-152.
20. Heidbreder CA, Oertle T, Feldon J: Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine. Neuroscience, 1999, 89, 701-715.
21. Koob, GF, Le Moal M: Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 2001, 24, 97-129.
22. Krysiak R, Obuchowicz E, Herman ZS: Role of corticotropin-releasing factor (CRF) in anxiety. Pol J Pharmacol, 2000, 52, 15-25.
23. Maddock RJ: The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci, 1999, 22, 310-316.
24. McCormick DA, Huguenard JR: A model of the electrophysiological properties of thalamocortical relay neurons. J Neurophysiol, 1992, 68, 1384-1399.
25. McCormick DA, Pape H-C: Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurones. J Physiol (Lond), 1996, 431, 319-342.
26. McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TF, Heninger GR, Price LH: Noradrenergic dysregulation during discontinuition of cocaine use in addicts. Arch Gen Psychiatry, 1994, 51, 713-719.
27. 1-adrenoceptors in specific regions of the mouse brain and spinal cord. J Neural Transm, 2005, 112, 1309-1319.
28. O'Dell LE, Sussman AE, Meyer KL, Neisewander JL: Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei. Neuropsychopharmacology, 1999, 20, 591-602.
29. Paine TA, Jackman SL, Olmstead MC: Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol, 2002, 13, 511-523.
30. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, 3rd edn., Academic Press, San Diego, CA, USA, 1997.
31. Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev, 1997, 25, 192-216.
32. Pontieri FE, Tanda G, Di Chiara G: Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA, 1995, 92, 12304-12308.
33. 1-adrenergic receptor subtype classification. Mol Pharmacol, 1994, 46, 221-226.
34. Puumala T, Greijus S, Narinen K, Haapalinna A, Riekkinen P Sr, Sirvio J: Stimulation of alpha-1 adrenergic receptors facilitates spatial learning in rats. Eur Neuropsychopharmacol, 1998, 8, 17-26.
35. Schmidt HD, Anderson SM, Famous KR, Kumaresan VR, Pierce RC: Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol, 2005, 526, 65-76.
36. Self DW: Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology, 2004,47, Suppl 1, 242-255.
37. Todtenkopf MS, Carreiras T, Melloni RH, Stellar JR: The dorsomedial shell of the nucleus accumbens facilitates cocaine-induced locomotor activity during the induction of behavioral sensitization. Behav Brain Res, 2002, 131, 9-16.
38. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD et al.: Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature, 1997, 386, 830-833.
39. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F et al.: Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci, 2003, 23, 11461-11468.
40. 1- adrenoceptor subtypes. I. Radioligand binding studies. J Pharmacol Exp Ther, 1998, 286, 841-847.